Alganelle Sederma partnership
Sederma, one of the world leaders in the field of bioactive ingredients intended for the Cosmetic industry, is pleased to announce a strong partnership with Alganelle, an innovative French biotechnology company at the cutting edge of microalgae synthetic biology for the sustainable development and production of natural molecules.
In line with Croda’s Purpose to use Smart science to improve lives™, Alganelle disruptive technology provides very high-quality raw material, safer and obtained from sustainable processes that respect the environment and biodiversity. Sederma strongly trusts in this move from chemical synthesis to synthetic biology for a cleaner production of its best sellers. Indeed, Sederma’s expertise in peptide science for cosmetic applications, combined with Alganelle unique know-how to engineer microalgae used as photosynthetic cell factories will allow the production of cosmetic active ingredients of the future.
This common project of biological synthesis of one of Sederma’s ingredient with Alganelle’s optimised microalgae platform is in the development phase and a patent will be published end of August this year. We will release more information in the upcoming months.
In line with Croda’s Purpose to use Smart science to improve lives™, Alganelle disruptive technology provides very high-quality raw material, safer and obtained from sustainable processes that respect the environment and biodiversity. Sederma strongly trusts in this move from chemical synthesis to synthetic biology for a cleaner production of its best sellers. Indeed, Sederma’s expertise in peptide science for cosmetic applications, combined with Alganelle unique know-how to engineer microalgae used as photosynthetic cell factories will allow the production of cosmetic active ingredients of the future.
This common project of biological synthesis of one of Sederma’s ingredient with Alganelle’s optimised microalgae platform is in the development phase and a patent will be published end of August this year. We will release more information in the upcoming months.